Empowering Better Health

e4health tackles data, quality, and revenue challenges empowering your teams to focus on better care.

Our Leaders

Expertise: Webinars and White Papers

Partnerships

Investors

Upcoming Events

News & Blog

Taking care of the business and quality of healthcare

e4health cares for the quality, data, and results of your healthcare, so that you can care for your patients.

Health IT Consulting

Enterprise Program Management and Governance

Legacy Data Migration and Validation

Legacy System Support

IT and Project Team Staffing

Clinical Informatics Solutions

Data Analytics

Testing Management and Coordination

Go-Live Support

Mid-Revenue Cycle
Coding
CDI

Auditing

Risk Adjustment and HCCs

Education and Training

Health Information Management

eMPI Remediation and Ongoing Management

Clinical Data Abstraction

Legacy Data Migration and Validation

Document Management

Interim Leadership and Staffing

Technology

Software Solutions

AI and Automation Solutions
Today’s Tip: Drug-induced Neuropathy
Drug-induced neuropathy (D62.0) is a diagnosis often missed by even the savviest and seasoned coders. It is sometimes seen in documentation as ‘CIPN’ (chemotherapy-induced peripheral neuropathy) and is a common side effect caused by antineoplastic agents.  Treatment includes steroids and nerve pain medication such as Gabapentin.

Drugs related to neuropathy

The most likely chemotherapy drugs related to neuropathy include platinum drugs, such as oxaliplatin; taxanes, such as docetaxel; vinca alkaloids, such as vincristine; and myeloma treatments, such as bortezomib.  This code can also be accompanied by another code for the adverse effect (T36-T50) to identify the drug.